to apply clinical skills necessaryto preventclinical deterioration of a patient
Moderate interactions ... thosemay causedeterioration in the clinical status of a patient
Notwithstanding , we must acknowledgecould ... contributeto the clinical deterioration of the patient
Otezla 's abilityto preventclinical deterioration in patients with COVID-19
to adverse events including threat to life , due to the stress caused by transportationmay leadto adverse events including threat to life , due to the stress caused by transportation
in intensive care unit ( ICU ) transfer , cardiac arrest ( CA ) , and/or deathcan resultin intensive care unit ( ICU ) transfer , cardiac arrest ( CA ) , and/or death
increased morbidity and mortality.18 Such deterioration may be due to the severity of the patient ’s disease ( and therefore not preventable or expectedcausesincreased morbidity and mortality.18 Such deterioration may be due to the severity of the patient ’s disease ( and therefore not preventable or expected
the premises for paralytic ileuscreatesthe premises for paralytic ileus
us to begin his therapy soonerpromptedus to begin his therapy sooner
from cyclosporine - mediated suppression of proliferation , cytotoxicity , and inflammatory cytokine production of TCR α / β+ CD4-resultedfrom cyclosporine - mediated suppression of proliferation , cytotoxicity , and inflammatory cytokine production of TCR α / β+ CD4-
from cyclosporine - mediated suppression of proliferation , cytotoxicity , and inflammatory cytokine production of TCR β / β+ CD4- CD8- T lymphocytes in vivoresultedfrom cyclosporine - mediated suppression of proliferation , cytotoxicity , and inflammatory cytokine production of TCR β / β+ CD4- CD8- T lymphocytes in vivo